This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.

You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/health/6216534.stm

The article has changed 10 times. There is an RSS feed of changes available.

Version 1 Version 2
Expert drug trial safety advice Expert drug trial safety advice
(10 minutes later)
Experts investigating the drug trial which almost killed six young volunteers have made 22 recommendations on how to avoid such mistakes again.Experts investigating the drug trial which almost killed six young volunteers have made 22 recommendations on how to avoid such mistakes again.
The group, set up by the health secretary, says some drugs may be best given to people who are already ill.The group, set up by the health secretary, says some drugs may be best given to people who are already ill.
Also, doctors should have safety assessment training and an expert group should advise the government's drug regulatory body, the report said.Also, doctors should have safety assessment training and an expert group should advise the government's drug regulatory body, the report said.
But it added trials could only be judged on a "case by case" basis.But it added trials could only be judged on a "case by case" basis.
The report by the expert scientific group, led by Professor Gordon Duff, took into account what happened during the trail of the experimental drug TGN 1412 at Northwick Park Hospital in north London in March.
The drug was designed to treat multiple sclerosis, leukaemia and arthritis.
Its makers, German biotech company TeGenero, thought it would subtly "re-tune" the immune system.
But instead it sent the immune system into overdrive with catastrophic consequences.
All six men who were given the drug suffered multiple organ failure.
The worst affected, Ryan Wilson, had to have fingers and toes amputated.
The volunteers are launching a multi-million pound damages claim against Parexel, the research company that conducted the trial at.
The lawyer representing three of the seven victims of the TGN1412 clinical drug trials welcomed the report but called for a more far reaching independent enquiry to be launched.